STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Cash Flows From Operating Activities
Net loss	$ (56,097)	$ (789,347)
Adjustments to reconcile net loss to net cash used by operating activities:
Stock options issued for research and development expense	142,396	465,345
Stock options issued for consulting services	11,406	45,811
Stock options granted for officer compensation	65,327	0
Stock award for research and development expense	18,300	16,680
Loss on debt extinguishment	29,780	33,932
(Gain) on debt extinguishment, related parties	(287,602)	0
Non cash interest expense	16,104	38,000
Accretion of debt discount	14,024	35,091
Change in derivative liabilities	(89,948)	6,149
Changes in operating assets and liabilities:
Increase accounts payable and accrued liabilities	18,585	39,070
Increase accounts payable and accrued liabilities - related party	55,964	40,620
Net cash used by operating activities	(61,761)	(68,649)
Cash Flows From Investing Activities
Net cash provided from (used by) investing activities	0	0
Cash Flows From Financing Activities
Payment on unsecured loan	(100,000)	0
Proceeds from related party advances	162,000	66,000
Net cash provided from financing activities	62,000	66,000
Decrease in cash and cash equivalents	239	(2,649)
Cash at beginning of year	420	3,069
Cash at end of period	659	420
SUPPLEMENTAL DISCLOSURES
Interest paid	0	0
Income taxes paid	0	0
SUPPLEMENTAL NON-CASH FINANCING ACTIVITIES
Common stock issued under amended note	55,644	52,500
Debt discount from amended convertible note	0	29,461
Accrued interest payable modified to Note amended	16,000	12,000
Derecognition of derivative liability	233,365	0
Derivative liability associated with warrants	$ 0	$ 2,012